Syros Non Current Assets Total from 2010 to 2024

SYRS Stock  USD 0.25  0.01  3.85%   
Syros Pharmaceuticals Non Current Assets Total yearly trend continues to be comparatively stable with very little volatility. Non Current Assets Total will likely drop to about 21.7 M in 2024. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2014-12-31
Previous Quarter
21.8 M
Current Value
21.1 M
Quarterly Volatility
19.9 M
 
Yuan Drop
 
Covid
Check Syros Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syros Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 5.4 M or Selling General Administrative of 18.9 M, as well as many indicators such as Price To Sales Ratio of 21.1, Dividend Yield of 0.0 or PTB Ratio of 13.91. Syros financial statements analysis is a perfect complement when working with Syros Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Syros Pharmaceuticals Correlation against competitors.
For more information on how to buy Syros Stock please use our How to Invest in Syros Pharmaceuticals guide.

Latest Syros Pharmaceuticals' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Syros Pharmaceuticals over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Syros Pharmaceuticals' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Syros Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Syros Non Current Assets Total Regression Statistics

Arithmetic Mean14,839,370
Geometric Mean6,230,067
Coefficient Of Variation107.36
Mean Deviation14,058,844
Median5,815,000
Standard Deviation15,931,752
Sample Variance253.8T
Range45.4M
R-Value0.78
Mean Square Error107.1T
R-Squared0.61
Significance0.0006
Slope2,778,185
Total Sum of Squares3553.5T

Syros Non Current Assets Total History

202421.7 M
202323.2 M
202233.1 M
202146.4 M
202034.7 M
201935.5 M
2018M

About Syros Pharmaceuticals Financial Statements

Syros Pharmaceuticals shareholders use historical fundamental indicators, such as Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Syros Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Syros Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Syros Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total23.2 M21.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Syros Stock Analysis

When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.